ARCHIVES

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

This article is from The Cancer Letter archive.

Vol. 18 No. 05 | January 31, 1992

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings For Feb., March Listed

January 25, 1991

NCAB Committee Approves Concepts For Recompetition Of CIDAC, Two Other Contracts

July 1, 1983

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

November 7, 2008

NCI Offers Bibliography On Risk Communication.

March 23, 2001

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

Sentinel Lymph Node Excision Has No Impact on Survival

August 26, 2011